Circulating MicroRNAs characterizing patients with insufficient coronary collateral artery function

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Hakimzadeh, Nazanin ^a   Nossent, A Yaël ^b   Van Der Laan, Anja M ^a   Schirmer, Stephan H ^c   De Ronde, Maurice W J ^a   Pinto Sietsma, Sara Joan ^a   Van Royen, Niels ^d   Quax, Paul H A ^b   Hoefer, Imo E ^e   Piek, Jan J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c SAARLAND UNIVERSITY   (Germany)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 10B; MICRORNA 126; MICRORNA 15A; MICRORNA 16; MICRORNA 223; MICRORNA 30D; MICRORNA 423 5P; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY OCCLUSION; DISEASE CLASSIFICATION; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; MALE; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UPREGULATION; VALIDATION PROCESS; AGED; BLOOD; CLASSIFICATION; COLLATERAL CIRCULATION; CORONARY BLOOD VESSEL; GENETICS; LEUKOCYTE; MIDDLE AGED; PATHOPHYSIOLOGY; VALIDATION STUDY;

AGED; COLLATERAL CIRCULATION; CORONARY VESSELS; FEMALE; HUMANS; LEUKOCYTES; MALE; MICRORNAS; MIDDLE AGED;

EID: 84947461027     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0137035     Document Type: Article

References (34)

1. Faber JE, Chilian WM, Deindl E, van Royen N, Simons M. A brief etymology of the collateral circulation. Arteriosclerosis, thrombosis, and vascular biology. 2014; 34(9):1854-9. doi: 10.1161/ATVBAHA.114. 303929 PMID: 25012127
2. Elsman P, van 't Hof AW, de Boer MJ, Hoorntje JC, Suryapranata H, Dambrink JH, et al. Role of collateral circulation in the acute phase of ST-segment-elevation myocardial infarction treated with primary coronary intervention. Eur Heart J. 2004; 25(10):854-8. PMID: 15140533
3. Meier P, Gloekler S, Zbinden R, Beckh S, de Marchi SF, Zbinden S, et al. Beneficial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements. Circulation. 2007; 116(9):975-83. PMID: 17679611
4. Pijls NH, Bech GJ, el Gamal MI, Bonnier HJ, De Bruyne B, Van Gelder B, et al. Quantification of recruitable coronary collateral blood flow in conscious humans and its potential to predict future ischemic events. J Am Coll Cardiol. 1995; 25(7):1522-8. PMID: 7759702
5. Schirmer SH, Fledderus JO, Bot PT, Moerland PD, Hoefer IE, Baan J Jr, et al. Interferon-beta signaling is enhanced in patients with insufficient coronary collateral artery development and inhibits arteriogenesis in mice. Circ Res. 2008; 102(10):1286-94. doi: 10.1161/CIRCRESAHA.108.171827 PMID: 18420941
6. Schirmer SH, Bot PT, Fledderus JO, van der Laan AM, Volger OL, Laufs U, et al. Blocking interferon {beta} stimulates vascular smooth muscle cell proliferation and arteriogenesis. J Biol Chem. 2010; 285 (45):34677-85. doi: 10.1074/jbc.M110.164350 PMID: 20736166
7. Huntzinger E, Izaurralde E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet. 2011; 12(2):99-110. doi: 10.1038/nrg2936 PMID: 21245828
8. Nazari-Jahantigh M, Wei Y, Schober A. The role of microRNAs in arterial remodelling. Thromb Haemost. 2012; 107(4):611-8. doi: 10.1160/TH11-12-0826 PMID: 22371089
9. Welten SM, Bastiaansen AJ, de Jong RC, de Vries MR, Peters EA, Boonstra MC, et al. Inhibition of 14q32 MicroRNAs miR-329, miR-487b, miR-494, and miR-495 Increases Neovascularization and Blood Flow Recovery After Ischemia. Circ Res. 2014; 115(8):696-708. doi: 10.1161/CIRCRESAHA. 114.304747 PMID: 25085941
10. Condorelli G, Latronico MV, Cavarretta E. microRNAs in cardiovascular diseases: current knowledge and the road ahead. J Am Coll Cardiol. 2014; 63(21):2177-87. doi: 10.1016/j.jacc.2014.01.050 PMID: 24583309
11. van der Laan AM, Schirmer SH, de Vries MR, Koning JJ, Volger OL, Fledderus JO, et al. Galectin-2 expression is dependent on the rs7291467 polymorphism and acts as an inhibitor of arteriogenesis. Eur Heart J. 2012; 33(9):1076-84. doi: 10.1093/eurheartj/ehr220 PMID: 21831908
12. van der Hoeven NW, Teunissen PF, Werner GS, Delewi R, Schirmer SH, Traupe T, et al. Clinical parameters associated with collateral development in patients with chronic total coronary occlusion. Heart. 2013; 99(15):1100-5. doi: 10.1136/heartjnl-2013-304006 PMID: 23716567
13. Raffort J, Hinault C, Dumortier O, Van Obberghen E. Circulating microRNAs and diabetes: potential applications in medical practice. Diabetologia. 2015.
14. Epstein SE, Lassance-Soares RM, Faber JE, Burnett MS. Effects of aging on the collateral circulation, and therapeutic implications. Circulation. 2012; 125(25):3211-9. doi: 10.1161/CIRCULATIONAHA. 111.079038 PMID: 22733335
15. Kurotobi T, Sato H, Kinjo K, Nakatani D, Mizuno H, Shimizu M, et al. Reduced collateral circulation to the infarct-related artery in elderly patients with acute myocardial infarction. J Am Coll Cardiol. 2004; 44 (1):28-34. PMID: 15234401
16. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, et al. Circulating microRNAs in patients with coronary artery disease. Circ Res. 2010; 107(5):677-84. doi: 10.1161/CIRCRESAHA. 109.215566 PMID: 20595655
17. Tijsen AJ, Creemers EE, Moerland PD, de Windt LJ, van der Wal AC, Kok WE, et al. MiR423-5p as a circulating biomarker for heart failure. Circ Res. 2010; 106(6):1035-9. doi: 10.1161/CIRCRESAHA. 110.218297 PMID: 20185794
18. Hakimzadeh N, Verberne HJ, Siebes M, Piek JJ. The Future of Collateral Artery Research. Curr Cardiol Rev. 2013.
19. Kocaman SA, Arslan U, Tavil Y, Okuyan H, Abaci A, Cengel A. Increased circulating monocyte count is related to good collateral development in coronary artery disease. Atherosclerosis. 2008; 197(2):753-6. PMID: 17707383
20. Schober A, Nazari-Jahantigh M, Wei Y, Bidzhekov K, Gremse F, Grommes J, et al. MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nat Med. 2014; 20 (4):368-76. doi: 10.1038/nm.3487 PMID: 24584117
21. Koh W, Sheng CT, Tan B, Lee QY, Kuznetsov V, Kiang LS, et al. Analysis of deep sequencing micro- RNA expression profile from human embryonic stem cells derived mesenchymal stem cells reveals possible role of let-7 microRNA family in downstream targeting of hepatic nuclear factor 4 alpha. BMC Genomics. 2010; 11 Suppl 1:S6. doi: 10.1186/1471-2164-11-S1-S6 PMID: 20158877
22. Roth C, Rack B, Muller V, Janni W, Pantel K, Schwarzenbach H. Circulating microRNAs as bloodbased markers for patients with primary and metastatic breast cancer. Breast Cancer Res. 2010; 12(6): R90. doi: 10.1186/bcr2766 PMID: 21047409
23. Varendi K, Kumar A, Harma MA, Andressoo JO. miR-1, miR-10b, miR-155, and miR-191 are novel regulators of BDNF. Cell Mol Life Sci. 2014.
24. Donovan MJ, Lin MI, Wiegn P, Ringstedt T, Kraemer R, Hahn R, et al. Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization. Development. 2000; 127(21):4531-40. PMID: 11023857
25. Jiang H, Liu Y, Zhang Y, Chen ZY. Association of plasma brain-derived neurotrophic factor and cardiovascular risk factors and prognosis in angina pectoris. Biochemical and biophysical research communications. 2011; 415(1):99-103. doi: 10.1016/j.bbrc.2011.10.020 PMID: 22020095
26. Li X, Du N, Zhang Q, Li J, Chen X, Liu X, et al. MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy. Cell Death Dis. 2014; 5:e1479. doi: 10.1038/cddis. 2014.430 PMID: 25341033
27. Hakimzadeh N, Piek JJ. The coronary collateral circulation revisited. Neth Heart J. 2013; 21(3):144-5. doi: 10.1007/s12471-013-0376-0 PMID: 23359113
28. Dimmeler S, Nicotera P. MicroRNAs in age-related diseases. EMBO Mol Med. 2013; 5(2):180-90. doi: 10.1002/emmm.201201986 PMID: 23339066
29. Goldraich LA, Martinelli NC, Matte U, Cohen C, Andrades M, Pimentel M, et al. Transcoronary gradient of plasma microRNA 423-5p in heart failure: evidence of altered myocardial expression. Biomarkers. 2014; 19(2):135-41. doi: 10.3109/1354750X.2013.870605 PMID: 24506564
30. Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell. 2008; 15(2):261-71. doi: 10.1016/j. devcel.2008.07.002 PMID: 18694565
31. van Solingen C, Bijkerk R, de Boer HC, Rabelink TJ, van Zonneveld AJ. The Role of microRNA-126 in Vascular Homeostasis. Curr Vasc Pharmacol. 2013.
32. Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD, et al. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell. 2008; 15(2):272-84. doi: 10.1016/j.devcel.2008.07.008 PMID: 18694566
33. van Solingen C, Seghers L, Bijkerk R, Duijs JM, Roeten MK, van Oeveren-Rietdijk AM, et al. Antagomir- mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis. J Cell Mol Med. 2009; 13(8A):1577-85. doi: 10.1111/j.1582-4934.2008.00613.x PMID: 19120690
34. Kolibash AJ, Bush CA, Wepsic RA, Schroeder DP, Tetalman MR, Lewis RP. Coronary collateral vessels: spectrum of physiologic capabilities with respect to providing rest and stress myocardial perfusion, maintenance of left ventricular function and protection against infarction. Am J Cardiol. 1982; 50 (2):230-8. PMID: 7102555